about
Zika Virus: Diagnosis, Therapeutics, and VaccineAn Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors.Restriction of Zika Virus by Host Innate ImmunityPotent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance ProfilingMembrane Topology and Function of Dengue Virus NS2A ProteinZika virus produces noncoding RNAs using a multi-pseudoknot structure that confounds a cellular exonucleaseZika Virus Replicons for Drug DiscoveryA Multiplex Microsphere Immunoassay for Zika Virus DiagnosisA cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika VaccineRPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early Viral Protein AccumulationUnderstanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional AnalysisA Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in PatientsA live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse modelsReverse Genetics of Zika Virus.A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis.Inhibition of dengue virus by targeting viral NS4B proteinTwo distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assemblyA translation inhibitor that suppresses dengue virus in vitro and in vivoCharacterization of dengue virus NS4A and NS4B protein interaction.Mapping the Interactions between the NS4B and NS3 proteins of dengue virusDeterminants of Dengue Virus NS4A Protein OligomerizationRational design of a flavivirus vaccine by abolishing viral RNA 2'-O methylation.Dimerization of flavivirus NS4B protein.Targeting dengue virus NS4B protein for drug discovery.Biochemical and genetic characterization of dengue virus methyltransferase.Inhibition of Japanese encephalitis virus infection by flavivirus recombinant E protein domain III.Secondary structure and membrane topology of dengue virus NS4B N-terminal 125 amino acids.Generation and characterization of mouse monoclonal antibodies against NS4B protein of dengue virus.U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication.A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage.Functional Analysis of Glycosylation of Zika Virus Envelope Protein.An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction.Potential Mechanisms for Enhanced Zika Epidemic and Disease.Small Molecules and Antibodies for Zika Therapy.Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants.Zika Virus Vaccine: Progress and ChallengesA single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunityTreatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine CandidateUsing a virion assembly-defective dengue virus as a vaccine approachErratum for Chen et al., "Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate"
P50
Q24067899-09B15A94-1141-4FAA-8E79-F6D3528E7C56Q24261403-6E8467C9-AB0C-44A9-B7F8-671A2B99D85AQ24261405-F1EAEF2B-1DD5-4BFE-ABD8-361BBDECC64DQ26247399-CDF62421-C8AF-4379-9FA1-13D9E1CB370AQ27676369-57BCFC11-36FB-4DC8-A012-7AE0D822D9ACQ27883674-67CF3150-8B07-4466-AF14-738C0AE83661Q27928069-972A72DD-59D0-4CF6-B885-DFDFA4109595Q28223265-4C236D82-8407-4E64-8B3F-62B3EA28031DQ28729772-ADC45A0F-72CC-4CA6-835B-AA98ED372152Q28733415-D415E3A9-6753-419B-B141-512B09C32BEBQ28735954-80723CFD-E09A-4853-BB00-15F52DD6557BQ28954730-65BC203A-F9F8-422E-A8E8-4B656F94D46EQ29352360-BB122C94-B298-4534-9A5A-AC4C53E2E31EQ30145608-731A294C-1B41-43A0-8D2D-4754A69FF785Q33919503-2F767C36-A71C-47A1-B166-425048D66096Q34002195-22920BA4-5002-4276-BC16-318904539457Q34991051-DCCA9601-95E7-4E4C-BF7B-7E8FE3C115E9Q35191440-51DC87E4-14C8-4867-B3FF-657538682D65Q35487910-141E5985-B0B6-4597-B927-2150282B27BCQ35488254-079AC2AE-9AE0-44C2-9448-A325AD7F8732Q35760466-D149D957-4995-4515-973A-26202719C83FQ36827340-DB9CB5F5-041A-4542-B709-571A88D1410DQ37643762-73A1639E-DCAF-4CA0-AEEE-CDEA0346BD8EQ38386574-8C1C71D0-388B-48B0-8D68-3EF8E47FFAC8Q38975991-5F731F3E-CF11-41B5-BD5E-DD688944EAE7Q39147168-8DAEFDA4-FDD8-4A57-9D62-D9C3D6FDC239Q39177660-1070A709-A547-43D5-9029-C12580716C51Q39255013-7A3E217B-7117-413E-A90D-6E71B5CFCCF6Q39361574-56300B85-B7A1-4DCC-9520-3EC925FD09F8Q41689803-2170E1B6-77B7-4618-BD0A-31B7C6002F3DQ43046946-9DD41037-6CB6-42B1-A451-7FF18BBA04E4Q47548142-2CB04D92-7BEE-4781-9E03-7CA7D32072A8Q47550678-FA9F8C89-9F49-4D91-93C7-8E13BF5691ECQ47558373-AE61FC9B-F5C9-4C56-B72B-0394081238B7Q47558465-38EF31C9-8B00-4098-9B19-762CB5349ECCQ56347669-536BB17E-FEE8-46B5-89AF-1A1FDFD3ACFDQ57159546-EAD8695A-FC68-45D9-B59B-A07051D68CE4Q58725908-8AB204F7-26CF-4FE5-A8D6-671BCFA94780Q59354478-83031DCF-8836-4C9B-A9B5-D6959C4DD890Q63246198-D2D7860A-4F1A-4D9C-AB5F-1AF169EE33A2
P50
description
researcher ORCID ID = 0000-0003-0918-016X
@en
wetenschapper
@nl
name
Xuping Xie
@ast
Xuping Xie
@en
Xuping Xie
@es
Xuping Xie
@nl
type
label
Xuping Xie
@ast
Xuping Xie
@en
Xuping Xie
@es
Xuping Xie
@nl
prefLabel
Xuping Xie
@ast
Xuping Xie
@en
Xuping Xie
@es
Xuping Xie
@nl
P106
P31
P496
0000-0003-0918-016X